Cellebrite DI Ltd. (CLBT)

Every figure this model derived for CLBT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 13,225,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 276,001,000 CashAndCashEquivalentsAtCarryingValue 2025-12-31
current assets 575,850,000 AssetsCurrent 2025-12-31
current liabilities 369,657,000 LiabilitiesCurrent 2025-12-31
equity 484,318,000 StockholdersEquity 2025-12-31
ocf 173,544,000 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 475,675,000 RevenueFromContractWithCustomerExcludingAssessedTax 2025-12-31
sbc 44,892,000 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up CLBT on one particular measure came for.

RatioValue
cash operating margin25.91
current ratio6.25
current ratio reported1.56
deferred revenue growth27.94
dilution pct19.32
ebit cagr48.09
ebit yoy16.82
fcf margin33.7
growth cv0.28
operating margin13.98
owner earnings margin24.27
revenue growth18.56
revenue growth per share-0.63
roic25.21
rule of 4032.54
sbc pct revenue9.44

What to be careful about

What this model itself distrusts about CLBT's figures. Written by the derivation as it ran, not added afterwards.